U.S. FDA Probes Devices For Possible Contaminated Heparin
This article was originally published in PharmAsia News
U.S. FDA says it has received 97 reports, 11 of them of deaths, so far this year of adverse events that may have involved devices such as oxygenators and flush solutions containing heparin. The agency said it has not been able to determine the cause of the events and or whether contaminated heparin, such as the Chinese batch linked to 81 other deaths, were contained in the devices. The only two cases traced by the FDA so far showed the heparin was not contaminated, an agency spokeswoman said. (Click here for more - a subscription may be required
You may also be interested in...
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.